Us Attenuated Vaccine for Human Rabies Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Attenuated Vaccine for Human Rabies Market was valued at USD 0.10 Billion in 2022 and is projected to reach USD 0.15 Billion by 2030, growing at a CAGR of 5.4% from 2024 to 2030.
The United States is witnessing a significant surge in the attenuated vaccine market for human rabies, driven by heightened awareness and proactive public health initiatives. Rabies, a fatal viral disease transmitted through animal bites, has historically posed a public health challenge. However, recent trends indicate a positive shift towards effective prevention and control.
In 2024, the U.S. Department of Agriculture (USDA) commenced extensive oral rabies vaccination campaigns targeting wildlife, particularly raccoons, to curb the spread of rabies. These efforts are crucial, considering that approximately 90% of reported rabies cases in the U.S. originate from wildlife. The financial implications are substantial, with costs associated with rabies detection, prevention, and control exceeding $500 million annually. citeturn0search9
The human rabies vaccine market is experiencing robust growth. Valued at $1.1 billion in 2023, it is projected to reach $1.9 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.5%. This expansion is attributed to increased public awareness, government-led vaccination programs, and advancements in vaccine technology. citeturn0search7
A significant portion of this market growth is driven by post-exposure prophylaxis (PEP) treatments. In 2018, an estimated 55,000 individuals in the U.S. sought PEP following potential rabies exposure. This underscores the critical need for accessible and effective vaccines. citeturn0search2
Leading pharmaceutical companies are actively contributing to this upward trajectory. In April 2024, Sanofi launched Verorab®, an inactivated rabies vaccine designed for both pre-exposure and post-exposure prophylaxis across all age groups in the UK. Such innovations enhance the vaccine portfolio and improve accessibility for at-risk populations. citeturn0search7
Despite these advancements, challenges persist. Ensuring consistent vaccine supply, especially in remote areas, and maintaining public awareness about the importance of vaccination are ongoing concerns. Moreover, the financial burden of rabies prevention highlights the necessity for continued investment in research and development.
In conclusion, the U.S. attenuated vaccine market for human rabies is on a promising path, bolstered by public health efforts, technological advancements, and increased awareness. Sustained commitment from both public and private sectors is essential to maintain this momentum and achieve the ultimate goal of eliminating human rabies cases nationwide.
Additionally, it's worth noting that the 100 Gigabit Fiber Optic Transceiver Market is experiencing parallel growth, reflecting the broader trend of technological advancements across various sectors.
Get an In-Depth Research Analysis of the Global Attenuated Vaccine for Human Rabies Market Size And Forecast [2025-2032]
Â
AstraZeneca
GlaxoSmithKline
Merck & Co Inc
Sanofi Pasteur
Inc
Cadila Pharmaceuticals Ltd
Novartis AG
Pfizer Inc
Liaoning Yisheng Biopharmaceutical Co.
Ltd
Lanzhou Institute of Biological Products Co.
Ltd
Changchun Zhuoyi Biological Co.
Ltd
Guangzhou Nuocheng Biological Products Co.
Ltd
Ningbo Rongan Biopharmaceutical Co.
Ltd
Shandong Yidu Biotechnology Co.
Ltd
Chengdu Kanghua Biological Products Co.
Ltd
Wuhan Institute of Biological Products Co.
Ltd
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Attenuated Vaccine for Human Rabies Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Attenuated Vaccine for Human Rabies Market
Live Attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Intramuscular
Subcutaneous
Intradermal
Hospitals
Clinics
Research Laboratories
Veterinary Clinics
Vials
Syringes
Pre-filled Deliverables
Online Pharmacies
Retail Pharmacies
Direct Sales
Hospital Pharmacies
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Attenuated Vaccine for Human Rabies Market Research Analysis
1. Introduction of the Global Attenuated Vaccine for Human Rabies Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Attenuated Vaccine for Human Rabies Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Attenuated Vaccine for Human Rabies Market, By Type
6. Global Attenuated Vaccine for Human Rabies Market, By Application
7. Global Attenuated Vaccine for Human Rabies Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Attenuated Vaccine for Human Rabies Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/